M28 Capital Management LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
M28 Capital Management LP disclosed 9 US equity positions worth $58.6m in its Q2 2025 13F filing. The largest position was WVE at 62.8% of the reported book, followed by IVVD and TGTX. Against the Q1 2025 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 9 holdings.
What did M28 Capital Management LP own in Q2 2025? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 62.8% | $36.8m | 5,664,548 | 0% | held |
| 2 | IVVD INVIVYD INC | Healthcare | 11.3% | $6.6m | 9,248,250 | 0% | held |
| 3 | TGTX TG THERAPEUTICS INC | Healthcare | 9.9% | $5.8m | 161,600 | 0% | held |
| 4 | GUTS FRACTYL HEALTH INC | 5.1% | $3.0m | 1,856,117 | 0% | held | |
| 5 | PROQR THRAPEUTICS N V | 3.5% | $2.1m | 1,019,498 | 0% | held | |
| 6 | CRIS CURIS INC | 2.1% | $1.2m | 521,059 | 0% | held | |
| 7 | SLN SILENCE THERAPEUTICS PLC | 1.8% | $1.1m | 185,100 | 0% | held | |
| 8 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1.8% | $1.1m | 67,400 | 0% | held |
| 9 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 1.6% | $944.9k | 385,680 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.